Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8151)
All Articles published online
|
Publishing Process of This Article
|
Oct 21, 2014 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Morise Z, Kawabe N, Tomishige H, Nagata H, Kawase J, Arakawa S, Yoshida R, Isetani M. Recent advances in the surgical treatment of hepatocellular carcinoma. World J Gastroenterol 2014; 20(39): 14381-14392 [PMID: 25339825 DOI: 10.3748/wjg.v20.i39.14381] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v20/i39/14381.htm |
| Number | Citing Articles |
| 1 |
Hui Yao, Xiaojie Bian, Liang Mao, Xuejian Zi, Xiaopeng Yan, Yudong Qiu. Preoperative Enteral Nutritional Support in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Medicine 2015; 94(46): e2006 doi: 10.1097/MD.0000000000002006
|
| 2 |
Xin Guan, Meng Gao, Hong Xu, Chenghong Zhang, Hongyan Liu, Li Lv, Sa Deng, Dongyan Gao, Yan Tian. Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer. Drug Delivery 2016; 23(9): 3307 doi: 10.1080/10717544.2016.1176087
|
| 3 |
Jun‐Cheng Guo, Yi‐Jun Yang, Jian‐Quan Zhang, Min Guo, Li Xiang, Shu‐Feng Yu, Huang Ping, Liu Zhuo. microRNA‐448 inhibits stemness maintenance and self‐renewal of hepatocellular carcinoma stem cells through the MAGEA6‐mediated AMPK signaling pathway. Journal of Cellular Physiology 2019; 234(12): 23461 doi: 10.1002/jcp.28915
|
| 4 |
Yonglei Liu, Yutong Wang, Xiangjun Sun, Chuanzhong Mei, Liying Wang, Zengxia Li, Xiliang Zha. miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1. Oncotarget 2016; 7(12): 13491 doi: 10.18632/oncotarget.4821
|
| 5 |
Liyun Zheng, Shiji Fang, Fazong Wu, Weiqian Chen, Minjiang Chen, Qiaoyou Weng, Xulu Wu, Jingjing Song, Zhongwei Zhao, Jiansong Ji. Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study. Frontiers in Molecular Biosciences 2021; 7 doi: 10.3389/fmolb.2020.609322
|
| 6 |
Yuwen Yang, Huanqian Luo, Yang Zhao, Lu Li, Yan He, Fen Xi, Hai Jin, Ruru Gao, Qiong Luo, Jianhua Liu. Promoting the effect of microbubble-enhanced ultrasound on hyperthermia in rabbit liver. Journal of Medical Ultrasonics 2022; 49(2): 133 doi: 10.1007/s10396-021-01187-y
|
| 7 |
Jina Kim, Yong Tae Kim, Jae Geun Lee, Dai Hoon Han, Dong Jin Joo, Do Young Kim, Jinsil Seong. Liver-Directed Combined Radiation Therapy for Downstaging Beyond-Milan Hepatocellular Carcinoma to Liver Transplantation. International Journal of Radiation Oncology*Biology*Physics 2024; 119(4): 1171 doi: 10.1016/j.ijrobp.2024.01.221
|
| 8 |
Zenichi Morise. Laparoscopic liver resection for posterosuperior tumors using caudal approach and postural changes: A new technical approach. World Journal of Gastroenterology 2016; 22(47): 10267-10274 doi: 10.3748/wjg.v22.i47.10267
|
| 9 |
Nanbao Zhong, Guangming Lv, Zhonghua Chen. High Dose-Volume SBRT Following TACE Improves Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma. Journal of Cancer Therapy 2016; 7(02): 152 doi: 10.4236/jct.2016.72016
|
| 10 |
Zhuo Cheng, Xiaofeng Li, Jin Ding. Characteristics of liver cancer stem cells and clinical correlations. Cancer Letters 2016; 379(2): 230 doi: 10.1016/j.canlet.2015.07.041
|
| 11 |
Caiqun Bie, Yanfang Chen, Huijun Tang, Qing Li, Lu Zhong, Xiaojuan Peng, Ying Shi, Junqin Lin, Junlong Lai, Shenglan Wu, Shaohui Tang. Insulin-Like Growth Factor 1 Receptor Drives Hepatocellular Carcinoma Growth and Invasion by Activating Stat3-Midkine-Stat3 Loop. Digestive Diseases and Sciences 2022; 67(2): 569 doi: 10.1007/s10620-021-06862-1
|
| 12 |
Tomohiro Ishinuki, Shigenori Ota, Kohei Harada, Hiroomi Tatsumi, Keisuke Harada, Koji Miyanishi, Minoru Nagayama, Ichiro Takemasa, Toshio Ohyanagi, Thomas T Hui, Toru Mizuguchi. Health-related quality of life in patients that have undergone liver resection: A systematic review and meta-analysis. World Journal of Meta-Analysis 2021; 9(1): 88-100 doi: 10.13105/wjma.v9.i1.88
|
| 13 |
Takeshi Takahara, Go Wakabayashi, Toru Beppu, Arihiro Aihara, Kiyoshi Hasegawa, Naoto Gotohda, Etsuro Hatano, Yoshinao Tanahashi, Toru Mizuguchi, Toshiya Kamiyama, Tetsuo Ikeda, Shogo Tanaka, Nobuhiko Taniai, Hideo Baba, Minoru Tanabe, Norihiro Kokudo, Masaru Konishi, Shinji Uemoto, Atsushi Sugioka, Koichi Hirata, Akinobu Taketomi, Yoshihiko Maehara, Shoji Kubo, Eiji Uchida, Hiroaki Miyata, Masafumi Nakamura, Hironori Kaneko, Hiroki Yamaue, Masaru Miyazaki, Tadahiro Takada. Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study. Journal of Hepato-Biliary-Pancreatic Sciences 2015; 22(10): 721 doi: 10.1002/jhbp.276
|
| 14 |
Cai Qun Bie, Xu You Liu, Ming Rong Cao, Qiu Yan Huang, Hui Jun Tang, Min Wang, Guo Li Cao, Ting Zhuang Yi, Sheng Lan Wu, Wei Jie Xu, Shao Hui Tang. Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expression. Oncotarget 2016; 7(48): 79305 doi: 10.18632/oncotarget.13027
|
| 15 |
Si-bo Yang, Zi-han Zhou, Jin Lei, Xiao-wen Li, Qian Chen, Bo Li, Ye-wei Zhang, Yu-zhen Ge, Shi Zuo. TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC. Biology Direct 2023; 18(1) doi: 10.1186/s13062-023-00376-8
|
| 16 |
Yoshikuni Inokawa, Kenichi Inaoka, Fuminori Sonohara, Masamichi Hayashi, Mitsuro Kanda, Shuji Nomoto. Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors. Oncology Letters 2016; 12(5): 3662 doi: 10.3892/ol.2016.5141
|
| 17 |
Zenichi Morise, Go Wakabayashi. First quarter century of laparoscopic liver resection. World Journal of Gastroenterology 2017; 23(20): 3581-3588 doi: 10.3748/wjg.v23.i20.3581
|
| 18 |
Hongyan Zhai, Ping Liang, Xiao-ling Yu, Zhigang Cheng, Zhi-Yu Han, Fangyi Liu, Jie Yu. Microwave ablation in treating intrahepatic recurrence of hepatocellular carcinoma after liver transplantation: An analysis of 11 cases. International Journal of Hyperthermia 2015; 31(8): 863 doi: 10.3109/02656736.2015.1091953
|
| 19 |
|
| 20 |
Bo Zhou, Zhiping Yan, Rong Liu, Peng Shi, Sheng Qian, Xudong Qu, Liang Zhu, Wei Zhang, Jianhua Wang. Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma. Radiology 2016; 280(2): 630 doi: 10.1148/radiol.2016150719
|
| 21 |
Chunlin Xu, Weiwei Sun, Jinglei Liu, Haihong Pu, Yinghong Li. MiR-342-3p inhibits LCSC oncogenicity and cell stemness through HDAC7/PTEN axis. Inflammation Research 2022; 71(1): 107 doi: 10.1007/s00011-021-01521-7
|
| 22 |
Xinyao Hu, Hua Zhu, Shi Feng, Chaoqun Wang, Yingze Ye, Xiaoxing Xiong. Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.1006357
|
| 23 |
Andreas Andreou, Benjamin Struecker, Nathanael Raschzok, Felix Krenzien, Philipp Haber, Simon Wabitsch, Christoph Waldbaur, Eva-Maria Touet, Anne-Christine Eichelberg, Georgi Atanasov, Matthias Biebl, Marcus Bahra, Robert Öllinger, Moritz Schmelzle, Johann Pratschke. Minimal-invasive versus open hepatectomy for hepatocellular carcinoma: Comparison of postoperative outcomes and long-term survivals using propensity score matching analysis. Surgical Oncology 2018; 27(4): 751 doi: 10.1016/j.suronc.2018.10.005
|
| 24 |
Yiwei Dong, Qianqian Cai, Lisheng Fu, Haojie Liu, Mingzhe Ma, Xingzhong Wu, Tao Huang. Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/4873678
|
| 25 |
Manran Wu, Lei Zhang, Kexin Shi, Dongxu Zhao, Weipeng Yong, Lingling Yin, Ruizhe Huang, Guanglin Wang, Gang Huang, Mingyuan Gao. Polydopamine-Coated Radiolabeled Microspheres for Combinatorial Radioembolization and Photothermal Cancer Therapy. ACS Applied Materials & Interfaces 2023; 15(10): 12669 doi: 10.1021/acsami.2c19829
|
| 26 |
Xiaohua Xing, Dong Liang, Yao Huang, Yongyi Zeng, Xiao Han, Xiaolong Liu, Jingfeng Liu. The application of proteomics in different aspects of hepatocellular carcinoma research. Journal of Proteomics 2016; 145: 70 doi: 10.1016/j.jprot.2016.03.050
|
| 27 |
Takamasa Ohki, Mayuko Kondo, Yuki Karasawa, Satoshi Kawamura, Shuuya Maeshima, Kentaro Kojima, Michiharu Seki, Nobuo Toda, Yoshinobu Shioda, Kazumi Tagawa. Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index. Advances in Therapy 2017; 34(5): 1097 doi: 10.1007/s12325-017-0524-9
|
| 28 |
Zenichi Morise. Developments and perspectives of laparoscopic liver resection in the treatment of hepatocellular carcinoma. Surgery Today 2019; 49(8): 649 doi: 10.1007/s00595-019-1765-9
|
| 29 |
Jia-Yuan Huang, Kai Zhang, Dong-Qin Chen, Jing Chen, Bing Feng, Haizhu Song, Yitian Chen, Ziman Zhu, Lei Lu, Wei De, Rui Wang, Long-Bang Chen. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Oncotarget 2015; 6(21): 18613 doi: 10.18632/oncotarget.4317
|
| 30 |
Zhi-cheng Deng, Wen-zhu Jiang, Xiao-dong Tang, Shuang-hai Liu, Lei Qin, Hai-xin Qian. Laparoscopic hepatectomy versus open hepatectomy for hepatocellular carcinoma in 157 patients: A case controlled study with propensity score matching at two Chinese centres. International Journal of Surgery 2018; 56: 203 doi: 10.1016/j.ijsu.2018.06.026
|
| 31 |
Yao Huang, Jianxing Zeng, Teng Liu, Xinju Lin, Pengfei Guo, Jinhua Zeng, Weiping Zhou, Jingfeng Liu. <p>Prognostic Significance of Elevated Preoperative Serum CA125 Levels After Curative Hepatectomy for Hepatocellular Carcinoma</p>. OncoTargets and Therapy 2020; : 4559 doi: 10.2147/OTT.S236475
|
| 32 |
Wenjuan Xie, Xiaojing Qiao, Lingyue Shang, Jianming Dou, Xi Yang, Shouyi Qiao, Yanhua Wu. Knockdown of ZNF233 suppresses hepatocellular carcinoma cell proliferation and tumorigenesis. Gene 2018; 679: 179 doi: 10.1016/j.gene.2018.08.070
|
| 33 |
Yonghua Bi, Kewei Ren, Jianzhuang Ren, Ji Ma, Xinwei Han. Oxaliplatin Eluting CalliSpheres Microspheres for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.923585
|
| 34 |
Weihua Zhi, Jie Hou, Shupeng Fan, Yue Han. Delayed biopsy following completion of transarterial chemoembolization in patients with hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2022; 18(5): 1346 doi: 10.4103/jcrt.jcrt_732_22
|
| 35 |
|
| 36 |
Nikhar Chhaniwal, Cheng Li, Jiaxiang Wang, Guosheng Qiang, Tingyue Qi, Hendi Maher. Hepatocellular Carcinoma: Review of Current Treatment with a Focus on Transarterial Chemoembolization and Radiofrequency Ablation. Open Journal of Radiology 2015; 5(01): 50 doi: 10.4236/ojrad.2015.51009
|
| 37 |
Machaon M. Bonafede, Beata Korytowsky, Prianka Singh, Qian Cai, Katherine Cappell, Krutika Jariwala-Parikh, Bruce Sill, Neehar D. Parikh. Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer Therapy. Journal of Gastrointestinal Cancer 2020; 51(1): 217 doi: 10.1007/s12029-019-00230-z
|
| 38 |
Xiaohua Xing, Yao Huang, Sen Wang, Minhui Chi, Yongyi Zeng, Lihong Chen, Ling Li, Jinhua Zeng, Minjie Lin, Xiao Han, Xiaolong Liu, Jingfeng Liu. Comparative analysis of primary hepatocellular carcinoma with single and multiple lesions by iTRAQ-based quantitative proteomics. Journal of Proteomics 2015; 128: 262 doi: 10.1016/j.jprot.2015.08.007
|
| 39 |
Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Byung-Gon Na, Kyo-Won Lee, Gyu-Seong Choi, Joon Hyeok Lee. Nonanatomical resection is comparable with anatomical resection in solitary hepatocellular carcinoma <5 cm in the right posterior section. Medicine 2016; 95(51): e5382 doi: 10.1097/MD.0000000000005382
|
| 40 |
Feng Xia, Li-Li Wu, Wan-Yee Lau, Hong-Bo Huan, Xu-Dong Wen, Kuan-Sheng Ma, Xiao-Wu Li, Ping Bie. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients. World Journal of Gastroenterology 2016; 22(23): 5384-5392 doi: 10.3748/wjg.v22.i23.5384
|
| 41 |
Masahiro Yamamoto, Kazue Morishima, Kazuhiro Endo, Kentaro Shimodaira, Yuki Kimura, Yuichi Aoki, Masanobu Taguchi, Hideki Sasanuma, Yasunaru Sakuma, Shunji Watanabe, Naoki Morimoto, Naohiro Sata. Postoperative Outcomes of Laparoscopic Hepatic Resection Combined With Radiofrequency Ablation for Two or Three Hepatocellular Carcinomas: A Case Series of Nine Patients. Cureus 2024; doi: 10.7759/cureus.73864
|
| 42 |
Jun Lv, Yongkui Kong, Zhiqiang Gao, Yanmin Liu, Pengfei Zhu, Zujiang Yu. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma. The International Journal of Biochemistry & Cell Biology 2018; 101: 19 doi: 10.1016/j.biocel.2018.05.010
|
| 43 |
Qifan He, Jian Yang, Yonghai Jin. Development and Validation of TACE Refractoriness-Related Diagnostic and Prognostic Scores and Characterization of Tumor Microenvironment Infiltration in Hepatocellular Carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.869993
|
| 44 |
An Li, Ning Wu, Jingyu Sun. E2F1‑induced microRNA‑224‑5p expression is associated with hepatocellular carcinoma cell migration, invasion and epithelial‑mesenchymal transition via MREG. Oncology Letters 2022; 23(3) doi: 10.3892/ol.2022.13202
|
| 45 |
Maristela Pinheiro Freire, Ligia Câmera Pierrotti, Isabel Cristina Villela Soares Oshiro, Patrícia Rodrigues Bonazzi, Larissa Marques de Oliveira, Anna Silva Machado, Inneke Marie Van Der Heijden, Flavia Rossi, Silvia Figueiredo Costa, Luiz Augusto Carneiro D'Albuquerque, Edson Abdala. Carbapenem‐resistant A cinetobacter baumannii acquired before liver transplantation: Impact on recipient outcomes. Liver Transplantation 2016; 22(5): 615 doi: 10.1002/lt.24389
|
| 46 |
Zhi-Ming Zhang, Yu-Mei Zhang, Feng Yao, Ping Yi, Shang Huang, Jian-Yong Liu, Bang-De Xiang, Wei-Ping Yuan, Le-Qun Li. Analysis on Postoperative Efficacy of Radical Hepatectomy for Patients with Non-HBV/HCV Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention 2015; 16(8): 3479 doi: 10.7314/APJCP.2015.16.8.3479
|
| 47 |
Shu-Wen Zhang, Ning-Ning Zhang, Wen-Wen Zhu, Tian Liu, Jia-Yu Lv, Wen-Tao Jiang, Ya-Min Zhang, Tian-Qiang Song, Li Zhang, Yan Xie, Yong-He Zhou, Wei Lu. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.946531
|
| 48 |
Kunpeng Hu, Purun Lei, Zhicheng Yao, Chenhu Wang, Qingliang Wang, Shilei Xu, Zhiyong Xiong, He Huang, Ruiyun Xu, Meihai Deng, Bo Liu. Laparoscopic RFA with splenectomy for hepatocellular carcinoma. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0954-x
|
| 49 |
Nir Lubezky, Yaacov Goykhman, Richard Nakache, Ido Nachmany. Hepatocellular Carcinoma. 2016; : 467 doi: 10.1007/978-3-319-34214-6_31
|
| 50 |
Ya Gao, Haohao Lu, Zhifan Xiong. Efficacy and safety of tyrosine kinase inhibitors plus PD-1 inhibitor in patients with transarterial chemoembolization- refractory hepatocellular carcinoma: a two-center retrospective study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1231359
|
| 51 |
Jianfeng Huang, Weibiao Kang, Shubo Pan, Changjun Yu, Zhigang Jie, Changyu Chen, Fabio Ciccarone. NOL12 as an Oncogenic Biomarker Promotes Hepatocellular Carcinoma Growth and Metastasis. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/6891155
|
| 52 |
Omniya M. Abd-Elazeem, Nehal A.H.k. Osman, Nahla S. El-Shenawy. Bioactive Compounds of Seaweeds and Their Effects on Certain Types of Cancer. Avicenna Journal of Medical Biochemistry 2020; 8(2): 112 doi: 10.34172/ajmb.2020.16
|
| 53 |
Wei Zhao, Xue Jiang, Shuxia Yang. <p>lncRNA TUG1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma via Regulating miR-29c-3p/<em>COL1A1</em> Axis</p>. Cancer Management and Research 2020; : 6837 doi: 10.2147/CMAR.S256624
|
| 54 |
Arimasa Miyama, Zenichi Morise, Luca Aldrighetti, Giulio Belli, Francesca Ratti, Tan-To Cheung, Chung-Mau Lo, Shogo Tanaka, Shoji Kubo, Yukiyasu Okamura, Katsuhiko Uesaka, Kazuteru Monden, Hiroshi Sadamori, Kazuki Hashida, Kazuyuki Kawamoto, Naoto Gotohda, KuoHsin Chen, Akishige Kanazawa, Yutaka Takeda, Yoshiaki Ohmura, Masaki Ueno, Toshiro Ogura, Kyung-Suk Suh, Yutaro Kato, Atsushi Sugioka, Andrea Belli, Hiroyuki Nitta, Masafumi Yasunaga, Daniel Cherqui, Nasser Abdul Halim, Alexis Laurent, Hironori Kaneko, Yuichiro Otsuka, Ki-Hun Kim, Hwui-Dong Cho, Charles Chung-Wei Lin, Yusuke Ome, Yasuji Seyama, Roberto I. Troisi, Giammauro Berardi, Fernando Rotellar, Gregory C. Wilson, David A. Geller, Olivier Soubrane, Tomoaki Yoh, Takashi Kaizu, Yusuke Kumamoto, Ho-Seong Han, Ela Ekmekcigil, Ibrahim Dagher, David Fuks, Brice Gayet, Joseph F. Buell, Ruben Ciria, Javier Briceno, Nicholas O’Rourke, Joel Lewin, Bjorn Edwin, Masahiro Shinoda, Yuta Abe, Mohammed Abu Hilal, Mohammad Alzoubi, Minoru Tanabe, Go Wakabayashi. Multicenter Propensity Score-Based Study of Laparoscopic Repeat Liver Resection for Hepatocellular Carcinoma: A Subgroup Analysis of Cases with Tumors Far from Major Vessels. Cancers 2021; 13(13): 3187 doi: 10.3390/cancers13133187
|
| 55 |
Xiaohua Xing, Hui Yuan, Ying Sun, Kun Ke, Xiuqing Dong, Hui Chen, Xiaolong Liu, Bixing Zhao, Aimin Huang. ANXA2Tyr23 and FLNASer2152 phosphorylation associate with poor prognosis in hepatic carcinoma revealed by quantitative phosphoproteomics analysis. Journal of Proteomics 2019; 200: 111 doi: 10.1016/j.jprot.2019.03.017
|
| 56 |
Wei Yang, Hao Wu, Zhong-yi Zhang, Jung-chieh Lee, Song Wang, Yan-jie Wang, Wei Wu, Min-hua Chen, Kun Yan. Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantation. International Journal of Hyperthermia 2018; 34(1): 68 doi: 10.1080/02656736.2017.1324179
|
| 57 |
Takeshi Takahara, Go Wakabayashi, Hiroyuki Konno, Mitsukazu Gotoh, Hiroki Yamaue, Katsuhiko Yanaga, Jirou Fujimoto, Hironori Kaneko, Michiaki Unno, Itaru Endo, Yasuyuki Seto, Hiroaki Miyata, Masaru Miyazaki, Masakazu Yamamoto. Comparison of laparoscopic major hepatectomy with propensity score matched open cases from the National Clinical Database in Japan. Journal of Hepato-Biliary-Pancreatic Sciences 2016; 23(11): 721 doi: 10.1002/jhbp.405
|
| 58 |
Kazuhiro Nouso, Norihiro Kokudo, Masatoshi Tanaka, Ryoko Kuromatsu, Hiroki Nishikawa, Hidenori Toyoda, Naoki Oishi, Kenji Kuwaki, Masashi Kusanaga, Takuki Sakaguchi, Zenichi Morise, Satoshi Kitai, Masatoshi Kudo. Treatment of Hepatocellular Carcinoma with Child-Pugh C Cirrhosis. Oncology 2014; 87(Suppl. 1): 99 doi: 10.1159/000368152
|
| 59 |
Zhuo Cheng, Zhiying He, Yongchao Cai, Cheng Zhang, Gongbo Fu, Hengyu Li, Wen Sun, Changcheng Liu, Xiuliang Cui, Beifang Ning, Daimin Xiang, Tengfei Zhou, Xiaofeng Li, Weifen Xie, Hongyang Wang, Jin Ding. Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors. Cell Research 2019; 29(2): 124 doi: 10.1038/s41422-018-0111-x
|
| 60 |
Cai-Jie Lu, Yi-Feng He, Wei-Zhuang Yuan, Li-Jun Xiang, Jian Zhang, Yan-Rui Liang, Juan Duan, Yun-He He, Ming-Yi Li. Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells. World Journal of Gastroenterology 2017; 23(34): 6242-6251 doi: 10.3748/wjg.v23.i34.6242
|
| 61 |
Ying-Chen Xu, Chao-Jie Liang, Dong-Xin Zhang, Guan-Qun Li, Xia Gao, Jian-Zhu Fu, Feng Xia, Jia-Jun Ji, Li-Jun Zhang, Guang-Ming Li, Ji-Xiang Wu. LncSHRG promotes hepatocellular carcinoma progression by activating HES6. Oncotarget 2017; 8(41): 70630 doi: 10.18632/oncotarget.19906
|
| 62 |
Xuelian Cheng, Jingjing Li, Limei Feng, Songwei Feng, Xiao Wu, Yongming Li. The role of hypoxia-related genes in TACE-refractory hepatocellular carcinoma: Exploration of prognosis, immunological characteristics and drug resistance based on onco-multi-OMICS approach. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1011033
|
| 63 |
Dahai Wei, Yongyi Zeng, Xiaohua Xing, Hongzhi Liu, Minjie Lin, Xiao Han, Xiaolong Liu, Jingfeng Liu. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics. Journal of Proteome Research 2016; 15(2): 487 doi: 10.1021/acs.jproteome.5b00838
|
| 64 |
Zenichi Morise, Hidetoshi Katsuno, Kenji Kikuchi, Tomoyoshi Endo, Kazuhiro Matsuo, Yukio Asano, Akihiko Horiguchi. Laparoscopic Repeat Liver Resection—Selecting the Best Approach for Repeat Liver Resection. Cancers 2023; 15(2): 421 doi: 10.3390/cancers15020421
|
| 65 |
Noha Mohamed Hosni Shaheen, Naglaa Zayed, Nermine Magdi Riad, Hend H. Tamim, Rasha Mohamed Hosny Shahin, Dalia A. Labib, Suzan Mahrous ELsheikh, Reham Abdel Moneim, Ayman Yosry, Rania H khalifa. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients. Virus Research 2018; 255: 77 doi: 10.1016/j.virusres.2018.07.004
|
| 66 |
Z Morise, L Aldrighetti, G Belli, F Ratti, A Belli, D Cherqui, M Tanabe, G Wakabayashi, T T Cheung, C M Lo, S Tanaka, S Kubo, Y Okamura, K Uesaka, K Monden, H Sadamori, K Hashida, K Kawamoto, N Gotohda, K H Chen, A Kanazawa, Y Takeda, Y Ohmura, M Ueno, T Ogura, K S Suh, Y Kato, A Sugioka, H Nitta, M Yasunaga, N A Halium, A Laurent, H Kaneko, Y Otsuka, K H Kim, H-D Cho, C C-W Lin, Y Ome, Y Seyama, R I Troisi, G Berardi, F Roteller, G C Wilson, D A Geller, O Soubrane, T Yoh, T Kaizu, Y Kumamoto, H-S Han, E Ekmekcigil, I Dagher, D Fuks, B Gayet, J F Buell, R Ciria, J Briceno, N O'Rourke, J Lewin, B Edwin, M Shinoda, Y Abe, M Abu Hilal, M Alzoubi. Laparoscopic repeat liver resection for hepatocellular carcinoma: a multicentre propensity score-based study. British Journal of Surgery 2020; 107(7): 889 doi: 10.1002/bjs.11436
|